Clinical Trial Update: Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fludarabine plus cytarabine versus high-dose cytarabine in core-binding factor acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Core-binding Factor Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia, Core-Binding Factor | Phase 4 | Status: COMPLETED